Published in Am J Kidney Dis on January 01, 1995
Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice. J Gen Intern Med (1997) 1.36
Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol (2007) 1.33
Case-control study of 10 years of comprehensive diabetes care. West J Med (2000) 1.30
Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation. BMJ (1995) 1.22
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med (2004) 1.05
Endothelial dysfunction and microvascular complications in type 1 diabetes mellitus. J Korean Med Sci (2008) 1.05
Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002. J Gen Intern Med (2006) 1.03
Microalbuminuria in diabetes mellitus. CMAJ (2002) 0.97
Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol (2008) 0.96
Henoch Schönlein nephritis: clinical findings related to renal function and morphology. Pediatr Nephrol (2004) 0.94
Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review. Indian J Endocrinol Metab (2012) 0.87
Identifying and slowing progressive chronic renal failure. Can Fam Physician (2001) 0.86
G-CSF prevents progression of diabetic nephropathy in rat. PLoS One (2013) 0.83
Microalbuminuria in normal Korean children. Yonsei Med J (2011) 0.83
Diabetic nephropathy. Prevention and early referral. Can Fam Physician (2000) 0.79
Significance of microalbuminuria in relation to subclinical coronary atherosclerosis in asymptomatic nonhypertensive, nondiabetic subjects. J Korean Med Sci (2013) 0.79
Is oxidative stress related to childhood urolithiasis? Pediatr Nephrol (2014) 0.78
Regression and progression of microalbuminuria in adolescents with childhood onset diabetes mellitus. Ann Pediatr Endocrinol Metab (2015) 0.76
Identification of biomarkers for type 2 diabetes and its complications: a bioinformatic approach. Int J Biomed Sci (2007) 0.75
Physical activity alters urinary albumin/ creatinine ratio in type 1 diabetic patient. J Sports Sci Med (2004) 0.75
Case-based study: from prediabetes to complications--opportunities for prevention. PLoS Med (2005) 0.75
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest (1968) 10.35
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med (1984) 5.35
Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med (1984) 5.21
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 4.46
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation (1996) 3.88
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol (1995) 3.24
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet (1983) 3.01
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed) (1982) 2.99
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2000) 2.97
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
The immune complex glomerulonephritis of bacterial endocarditis. Medicine (Baltimore) (1972) 2.82
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant (2014) 2.67
Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest (1981) 2.50
Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis (1999) 2.38
Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) (1987) 2.35
Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int (2001) 2.35
A scientific registry of transplant recipients bayesian method for identifying underperforming transplant programs. Am J Transplant (2014) 2.35
The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol (1995) 2.32
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med (1989) 2.21
Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med (1979) 2.21
Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest (1976) 2.21
Structural-functional correlations in renal disease. II. The correlations. Hum Pathol (1970) 2.18
Glomerular cell culture. Lab Invest (1985) 2.16
OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant (2015) 2.11
Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother (1984) 2.09
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
OPTN/SRTR 2012 Annual Data Report: kidney. Am J Transplant (2014) 2.01
The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 2.01
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest (1971) 1.94
Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. Kidney Int (1993) 1.90
Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med (1987) 1.87
Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology (1995) 1.86
Microalbuminuria as predictor of increased mortality in elderly people. BMJ (1990) 1.85
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
OPTN/SRTR 2011 Annual Data Report: kidney. Am J Transplant (2013) 1.84
The glomerular mesangium. Kidney Int (1980) 1.83
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Urinary albumin excretion during exercise in juvenile diabetes. A provocation test for early abnormalities. Scand J Clin Lab Invest (1975) 1.79
OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant (2015) 1.79
Is diabetic nephropathy an inherited complication? Kidney Int (1992) 1.79
Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74
Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int (1987) 1.74
Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res (2001) 1.72
The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest (1984) 1.72
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70
Human glomerular cells in vitro: isolation and characterization. Transplant Proc (1980) 1.69
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) (1986) 1.68
Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int (1987) 1.68
Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest (1986) 1.67
Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis. Yale J Biol Med (1967) 1.67
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res (1980) 1.63
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes (1992) 1.60
OPTN/SRTR 2012 Annual Data Report: liver. Am J Transplant (2014) 1.59
Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ (1993) 1.58
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A (1992) 1.58
Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am J Pathol (1987) 1.57
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol (1988) 1.55
Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int (2001) 1.55
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A (1994) 1.54
Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med (1982) 1.54
Risk factors for cancer in renal transplant recipients. Transplantation (1999) 1.54
Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med (1993) 1.54
The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology (1982) 1.54
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia (1981) 1.53
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes (1978) 1.52
Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes (1995) 1.51
Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function. Nephrol Dial Transplant (1999) 1.51
Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia (1990) 1.49
Maximum tubular reabsorption capacity for glucose and renal hemodynamcis during rapid hypertonic glucose infusion in normal and diabetic subjects. Scand J Clin Lab Invest (1971) 1.49
OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant (2013) 1.48
Evaluation of living renal donors. The current practice of US transplant centers. Transplantation (1995) 1.47
Monitoring kidney function in diabetic nephropathy. Diabetologia (1994) 1.47
Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry (1983) 1.47
The kidney in diabetes. Am J Med (1981) 1.47
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int (2000) 1.46
Progression of diabetic nephropathy. Kidney Int (2001) 1.46
Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study. J Intern Med (2003) 1.45